Clinical Trial Update: Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Fianlimab with cemiplimab and chemotherapy, or cemiplimab with chemotherapy, in patients with pleural mesothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Mesothelioma

Drugs mentioned

• Cemiplimab (cemiplimab)
• Fianlimab (fianlimab)

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Pleural Mesotheliomas | Phase 2 | Status: NOT_YET_RECRUITING